Inflammation News and Research

RSS

SARS-CoV-2 suppresses ACE2 activity in COVID-19 patients

A recent study conducted by a team of international scientists has revealed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19), suppresses the expression and function of human angiotensin-converting enzyme 2 (ACE2) and induces the expression of interferon-stimulated genes at the initial phase of infection. The study is currently available on the bioRxiv* preprint server.

20 Nov 2020

Furin inhibition may mitigate severe COVID-19, study finds

Dr. Kara Fitzgerald, a researcher at the Institute for Functional Medicine in the United States, has explained the role of furin protease in developing severe COVID-19 illness.

20 Nov 2020

Move to ban sales of new petrol and diesel cars could benefit the health of professional drivers

As the Government announced today it will bring forward a ban on sales of new petrol and diesel cars by five years to 2030, new research shows professional drivers would benefit from improvements to their respiratory health, reducing their risks of cancers caused by their work.

20 Nov 2020

Study investigates link between myocarditis and COVID-19

As the COVID-19 pandemic evolves, so too does research into its effects on heart health. One particular area of interest for physicians involves whether COVID-19 leads to inflammation of the heart muscle, a condition known as myocarditis.

19 Nov 2020

Texas Heart Institute to participate in a study to treat ARDS in hospitalized COVID-19 patients

Texas Heart Institute has been selected as one of up to 60 sites in the world to participate in an international investigative study seeking to aid COVID-19 patients who develop acute respiratory distress syndrome (ARDS).

19 Nov 2020

Researchers uncover potential new target to fight inflammatory diseases

An international team of researchers have uncovered a drug-like compound that blocks a crucial inflammatory pathway, potentially paving the way for a new treatment for a host of diseases - including COVID-19.

19 Nov 2020

Study shows link between COPD and the gut microbiome

Research led by the Centenary Institute, the University of Technology Sydney and the University of Queensland has shown for the first time a link between chronic obstructive pulmonary disease (COPD), an often fatal lung condition, and the gut microbiome.

19 Nov 2020

New, non-invasive method for diagnosing and preventing colorectal cancer

Researchers from the University of Alicante(UA) and Alicante General University Hospital's Institute for Health and Biomedical Research (ISABIAL) have developed a new non-invasive method for diagnosing and preventing colorectal cancer (CRC) through the analysis of volatile organic compounds in stool samples.

19 Nov 2020

Teenagers facing COVID-19 and EVALI show similar symptoms

A UC Davis Health pediatric team presented a powerful case series of three teenagers who had unexplained breathing problems during the COVID-19 pandemic.

19 Nov 2020

Study shows new route for treating myocardial infarction

When the heart develops, some of its coronary blood vessels develop from cells lining the inner surface of the heart's ventricular chambers (endocardium). Novel

19 Nov 2020

SARS-CoV-2 is not associated with adverse pregnancy outcomes

A recent study examined the risks of SARS-CoV-2 infection during pregnancy, finding that no severe adverse outcomes are expected to either party.

19 Nov 2020

Scientists discover potential strategy to prevent inflammation in COVID-19 patients

The COVID-19 pandemic continues to cause significant illness and death while treatment options remain limited. St. Jude Children's Research Hospital scientists have discovered a potential strategy to prevent life-threatening inflammation, lung damage and organ failure in patients with COVID-19. The research appeared online in the journal Cell.

19 Nov 2020

Researchers report first spectroscopic imaging-based studies of neurological injury in COVID-19 patients

One of the first spectroscopic imaging-based studies of neurological injury in COVID-19 patients has been reported by researchers at Massachusetts General Hospital (MGH) in the American Journal of Neuroradiology.

19 Nov 2020

RUDN University dentists identify reason for early deterioration of dental implants

A team of dentists from RUDN University confirmed that a change in the dominant side of chewing is a reason for the early deterioration of dental implants.

19 Nov 2020

Immunotherapies effective against lung cancer, melanoma may also work against rare skin tumor

Cutaneous angiosarcoma is a rare, highly aggressive skin tumor found primarily on the scalps of older White people, but based on new research from the University of North Carolina School of Medicine and the Lineberger Comprehensive Cancer Center, immunotherapies effective against lung cancer and melanoma may also work against this cancer.

18 Nov 2020

COVID-19 during pregnancy can cause placental inflammation and impaired immunity

A new study conducted by a team of researchers at Johns Hopkins University, USA, has observed how pregnant women infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) show stunted antiviral immune responses.

18 Nov 2020

Severe COVID-19 complications linked to gut barrier breakdown

A new study claims that severe COVID-19 is caused by a positive feedback loop triggered by systemic inflammation and mediated by abnormal gut permeability. This finding could potentially help open up new avenues of treatment.

18 Nov 2020

SARS-CoV-2 causes a unique cytokine storm, study finds

A new study published on the preprint server medRxiv* in November 2020 reports some of the unique elements of COVID-19-induced CRS and how understanding these distinctive characteristics of the disease could help in formulating specific interventions and therapies.

18 Nov 2020

COVID-19's harmful neurological effects are more common in patients with hypertension, diabetes

Some patients with COVID-19 are at higher risk of neurological complications like bleeding in the brain and stroke, according to a study being presented at the annual meeting of the Radiological Society of North America.

18 Nov 2020

Diabetes and hypertension may increase the risk of COVID-19 brain complications

New data has revealed those with type 2 diabetes and hypertension are at an increased risk of neurological complications following infection with COVID-19.

18 Nov 2020

Inflammation News and Research

SARS-CoV-2 suppresses ACE2 activity in COVID-19 patients

Furin inhibition may mitigate severe COVID-19, study finds

Move to ban sales of new petrol and diesel cars could benefit the health of professional drivers

Study investigates link between myocarditis and COVID-19

Texas Heart Institute to participate in a study to treat ARDS in hospitalized COVID-19 patients

Researchers uncover potential new target to fight inflammatory diseases

Study shows link between COPD and the gut microbiome

New, non-invasive method for diagnosing and preventing colorectal cancer

Teenagers facing COVID-19 and EVALI show similar symptoms

Study shows new route for treating myocardial infarction

SARS-CoV-2 is not associated with adverse pregnancy outcomes

Scientists discover potential strategy to prevent inflammation in COVID-19 patients

Researchers report first spectroscopic imaging-based studies of neurological injury in COVID-19 patients

RUDN University dentists identify reason for early deterioration of dental implants

Immunotherapies effective against lung cancer, melanoma may also work against rare skin tumor

COVID-19 during pregnancy can cause placental inflammation and impaired immunity

Severe COVID-19 complications linked to gut barrier breakdown

SARS-CoV-2 causes a unique cytokine storm, study finds

COVID-19's harmful neurological effects are more common in patients with hypertension, diabetes

Diabetes and hypertension may increase the risk of COVID-19 brain complications

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News